Is there any association between Serum anti-HSP27 antibody level and the presence of metabolic syndrome; population based case-control study
By:
Fatemeh Sadabadi, Alireza Heidari-Bakavoli, Habibollah Esmaily, Susan Darroudi, Maryam Tayefi, Zahra Asadi, Seyed Mohammad Reza Parizadeh, Shima Tavalaie, Najmeh malekzadeh, Kiana Hosseinpour Moghaddam, Azam Rastgar Moghadam, Amir Hosein Sahebkar, Narges Fereydouni, Elham Barati, Mahmoudreza Azarpazhooh, Seyyed Javad Hosseini, Mohammad Tayyebi, Mahmoud Ebrahimi, Gordon A. Ferns, Majid Ghayour-Mobarhan and Mohsen Mouhebati
References
- 1. Takata H, Fujimoto S. Metabolic syndrome. Nihon rinsho Japanese journal of clinical medicine. 2013;71(2):266-9.
- 2. Kargari M, Parizadeh SMR, Karimian MS, Farahmand SK, Sahebkar A, Esmaeili H, et al. Serum anti-HSP27 antibody titers in patients with metabolic syndrome, with or without diabetes mellitus. Comparative Clinical Pathology. 2016;25(4):895-901. DOI: 10.1007/s00580-016-2279-010.1007/s00580-016-2279-0
- 3. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. Jama. 2002;287(3):356-9. DOI: 10.1001/jama.287.3.35610.1001/jama.287.3.356
- 4. Brumpton BM, Camargo CA, Romundstad PR, Langhammer A, Chen Y, Mai X-M. Metabolic syndrome and incidence of asthma in adults: the HUNT study. European Respiratory Journal. 2013;42(6):1495-502. DOI: 10.1183/09031936.0004601310.1183/09031936.00046013
- 5. Alberti KGM, Zimmet P, Shaw J. The metabolic syndrome—a new worldwide definition. The Lancet. 2005;366(9491):1059-62. DOI: 10.1016/S0140-6736(05)67402-810.1016/S0140-6736(05)67402-8
- 6. Braun S, Bitton-Worms K, LeRoith D. The link between the metabolic syndrome and cancer. International journal of biological sciences. 2011;7(7):1003. DOI: 10.7150/ijbs.7.100310.7150/ijbs.7.1003
- 7. van Vliet-Ostaptchouk JV, Nuotio M-L, Slagter SN, Doiron D, Fischer K, Foco L, et al. The prevalence of metabolic syndrome and metabolically healthy obesity in Europe: a collaborative analysis of ten large cohort studies. BMC endocrine disorders. 2014;14(1):9. DOI: 10.1186/1472-6823-14-910.1186/1472-6823-14-9
- 8. Cameron AJ, Shaw JE, Zimmet PZ. The metabolic syndrome: prevalence in worldwide populations. Endocrinology and metabolism clinics of North America. 2004;33(2):351-75. DOI: 10.1016/j.ecl.2004.03.005
- 9. Miranda PJ, DeFronzo RA, Califf RM, Guyton JR. Metabolic syndrome: definition, pathophysiology, and mechanisms. American heart journal. 2005;149(1):33-45. DOI: 10.1016/j.ahj.2004.07.01310.1016/j.ahj.2004.07.013
- 10. Radons J. The Heat Shock Protein Chaperone Interaction Network as Guardian of the Proteome in Health and Disease. Current Immunology Reviews. 2017;13(1):2-3. DOI: 10.2174/157339551301170906115238
- 11. Gomez-Pastor R, Burchfiel ET, Thiele DJ. Regulation of heat shock transcription factors and their roles in physiology and disease. Nature Reviews Molecular Cell Biology. 2017. DOI: 10.1038/nrm.2017.7310.1038/nrm.2017.73
- 12. Lu XY, Chen L, Cai XL, Yang HT. Overexpression of heat shock protein 27 protects against ischaemia/reperfusion-induced cardiac dysfunction via stabilization of troponin I and T. Cardiovascular research. 2008;79(3):500-8. DOI: 10.1093/cvr/cvn091
- 13. Shams S, Shafi S, Bodman-Smith K, Williams P, Mehta S, Ferns GA. Anti-heat shock protein-27 (Hsp-27) antibody levels in patients with chest pain: association with established cardiovascular risk factors. Clinica chimica acta; international journal of clinical chemistry. 2008;395(1-2):42-6.
- 14. Ghayour-Mobarhan M, Sahebkar A, Parizadeh SM, Moohebati M, Tavallaie S, Rezakazemi-Bajestani SM, et al. Antibody titres to heat shock protein 27 are elevated in patients with acute coronary syndrome. International journal of experimental pathology. 2008;89(3):209-15. DOI: 10.1111/j.1365-2613.2008.00586.x10.1111/j.1365-2613.2008.00586.x
- 15. Pourghadamyari H, Moohebati M, Parizadeh SM, Falsoleiman H, Dehghani M, Fazlinezhad A, et al. Serum antibody titers against heat shock protein 27 are associated with the severity of coronary artery disease. Cell stress & chaperones. 2011;16(3):309-16. DOI: 10.1007/s12192-010-0241-710.1007/s12192-010-0241-7
- 16. Kuang H-J, Zhao G-J, Chen W-J, Zhang M, Zeng G-F, Zheng X-L, et al. Hsp27 promotes ABCA1 expression and cholesterol efflux through the PI3K/PKCζ/Sp1 pathway in THP-1 macrophages. European Journal of Pharmacology. 2017. DOI: 10.1016/j.ejphar.2017.06.01510.1016/j.ejphar.2017.06.015
- 17. Shi C, Chen Y-X, Diao C, Batulan Z, OBrien ER. Novel Atheroprotection Therapy: Reduction in Serum Lipid Levels by HSP27 Via Down-regulation of HNF1a and PCSK9 Expression. Am Heart Assoc; 2016.
- 18. Singh T, Newman AB. Inflammatory markers in population studies of aging. Ageing research reviews. 2011;10(3):319-29. DOI: 10.1016/j.arr.2010.11.00210.1016/j.arr.2010.11.002
- 19. Ghayour-Mobarhan M, Moohebati M, Esmaily H, Ebrahimi M, Parizadeh SMR, Heidari-Bakavoli AR, et al. Mashhad stroke and heart atherosclerotic disorder (MASHAD) study: design, baseline characteristics and 10-year cardiovascular risk estimation. International journal of public health. 2015;60(5):561-72. DOI: 10.1007/s00038-015-0679-6
- 20. Tremblay AJ, Morrissette H, Gagné J-M, Bergeron J, Gagné C, Couture P. Validation of the Friedewald formula for the determination of low-density lipoprotein cholesterol compared with β-quantification in a large population. Clinical biochemistry. 2004;37(9):785-90. DOI: 10.1016/j.clinbiochem.2004.03.00810.1016/j.clinbiochem.2004.03.008
- 21. Austin PC. A comparison of 12 algorithms for matching on the propensity score. Statistics in Medicine. 2014;33(6):1057-69. DOI: 10.1002/sim.600410.1002/sim.6004
- 22. Ghayour-Mobarhan M, Rahsepar A, Tavallaie S, Rahsepar S, Ferns G. The potential role of heat shock proteins in cardiovascular disease: evidence from in vitro and in vivo studies. Advances in Clinical Chemistry. 2009;48:27-72. DOI: 10.1016/S0065-2423(09)48002-810.1016/S0065-2423(09)48002-8
- 23. Kim J, Yenari M. Heat Shock proteins and the Stress Response. Primer on Cerebrovascular Diseases. 2017:273. DOI: 10.1016/B978-0-12-803058-5.00056-410.1016/B978-0-12-803058-5.00056-4
- 24. Abulafia-Lapid R, Elias D, Raz I, Keren-Zur Y, Atlan H, Cohen IR. T cell proliferative responses of type 1 diabetes patients and healthy individuals to human hsp60 and its peptides. Journal of autoimmunity. 1999;12(2):121-9. DOI: 10.1006/jaut.1998.026210.1006/jaut.1998.0262
- 25. Ghayour‐Mobarhan M, Sahebkar A, Parizadeh SMR, Moohebati M, Tavallaie S, RezaKazemi‐Bajestani SM, et al. Antibody titres to heat shock protein 27 are elevated in patients with acute coronary syndrome. International journal of experimental pathology. 2008;89(3):209-15. DOI: 10.1111/j.1365-2613.2008.00586.x10.1111/j.1365-2613.2008.00586.x
- 26. Kargari M, Tavassoli S, Avan A, Ebrahimi M, Azarpazhooh MR, Asoodeh R, et al. Relationship between serum anti-heat shock protein 27 antibody levels and obesity. Clinical Biochemistry. 2017. DOI: 10.1016/j.clinbiochem.2017.02.01510.1016/j.clinbiochem.2017.02.015
- 27. Viollet B, Guigas B, Garcia NS, Leclerc J, Foretz M, Andreelli F. Cellular and molecular mechanisms of metformin: an overview. Clinical science. 2012;122(6):253-70. DOI: 10.1042/CS2011038610.1042/CS20110386
- 28. Dai S, Tang Z, Cao J, Zhou W, Li H, Sampson S, et al. Suppression of the HSF1-mediated proteotoxic stress response by the metabolic stress sensor AMPK. The EMBO journal. 2015;34(3):275-93. DOI: 10.15252/embj.201489062
- 29. Ghayour-Mobarhan M, Lamb DJ, Vaidya N, Livingstone C, Wang T, Ferns GA. Heat shock protein antibody titers are reduced by statin therapy in dyslipidemic subjects: a pilot study. Angiology. 2005;56(1):61-8. DOI: 10.1177/000331970505600108
- 30. Moohebati M, Bidmeshgi S, Azarpazhooh MR, Daloee MH, Ghayour-Mobarhan M, Tavallaie S, et al. Simvastatin treatment reduces heat shock protein 60, 65, and 70 antibody titers in dyslipidemic patients: A randomized, double-blind, placebo-controlled, cross-over trial. Clin Biochem. 2011;44(2-3):192-7. DOI: 10.1016/j.clinbiochem.2010.09.01610.1016/j.clinbiochem.2010.09.016
- 31. Aryanpour R, Parizadeh SMR, Moohebati M, Tavallaie S, Sahebkar AH, Mohammadi S, et al. SimvastatinTreatment is not Associated with Changes in Serum Concentrations of Heat ShockProteins -60 and -70 in Patients with Dyslipidemia. Pharmaceutical Sciences.20(2):46-51.
- 32. Burut DFP, Borai A, Livingstone C, Ferns G. Serum heat shock protein 27 antigen and antibody levels appear to be related to the macrovascular complications associated with insulin resistance: a pilot study. Cell Stress and Chaperones. 2010;15(4):379-86. DOI: 10.1007/s12192-009-0152-710.1007/s12192-009-0152-7
Language: English
Page range: 179 - 187
Submitted on: Sep 15, 2018
Accepted on: Feb 9, 2019
Published on: May 2, 2019
Published by: Romanian Association of Laboratory Medicine
In partnership with: Paradigm Publishing Services
Publication frequency: 4 times per year
Related subjects:
© 2019 Fatemeh Sadabadi, Alireza Heidari-Bakavoli, Habibollah Esmaily, Susan Darroudi, Maryam Tayefi, Zahra Asadi, Seyed Mohammad Reza Parizadeh, Shima Tavalaie, Najmeh malekzadeh, Kiana Hosseinpour Moghaddam, Azam Rastgar Moghadam, Amir Hosein Sahebkar, Narges Fereydouni, Elham Barati, Mahmoudreza Azarpazhooh, Seyyed Javad Hosseini, Mohammad Tayyebi, Mahmoud Ebrahimi, Gordon A. Ferns, Majid Ghayour-Mobarhan, Mohsen Mouhebati, published by Romanian Association of Laboratory Medicine
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.